genprowebdirectory
GEN Edge
Video & Multimedia
Latest News
Login
Subscribe
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
GEN Protocols
Summits
Webinars
GEN Live
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Video & Multimedia
Latest News
Login
Subscribe
News
Artificial Intelligence
Machine Learning to Optimize Product Quality Measurement
Allergic Diseases
Trial Finds Experimental Immunotherapy Reduces Most Children’s Sensitivity to Peanuts
Coronavirus
Omicron’s Spike Protein Captured via Cryo-Electron Microscopy
Animal Models
Study Identifies Single Type of Spinal Cord Neuron That Coordinates Locomotion
Brain Cancer
Novel Strategy Revealed against Glioma through Mutated Gene
Insights
All
Trends for 2020
Trends for 2021
Artificial Intelligence
Machine Learning to Optimize Product Quality Measurement
Insights
Genetically Engineered Pigs Brighten Prospects of Pig-to-Human Kidney Transplantation
Cancer
Magnesium Enables Immune Cells to Tackle Infections and Cancer
Bioprocessing
Scale-Down Modeling a Must for Intensified Processes
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
A-Lists
Seven Biopharma Trends to Watch in 2022
A-Lists
Six of the Best Reports from the Front Line of Biotechnology
A-Lists
Top 10 RNA-Based Biopharmas
Coronavirus
Top 11 Best Selling COVID-19 Vaccines and Drugs of H1 2021
A-Lists
Top 10 Spatial Biology Companies
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
GEN Protocols
Summits
Webinars
GEN Live
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Latest
All
News
A-Lists
More
Lab Equipment
Agilent CEO: “We’re Not Just a One-Year Wonder!”
Liquid Biopsies
Blood Stake: Roche Raises Freenome Investment to $360M
Next-Generation Sequencing
X Marks the $100 Genome: Illumina Presents New Chemistry, Strong Results
T Cells
Jurassic Ambitions: TRexBio Targets Tregs with Janssen Collaboration
Microfluidics
Mainstream Approach: Lunaphore Envisions Spatial Biology in Every Lab
Cell Therapy
Lineage 2.0: Cell Therapy Developer Eyes Next Phase after Genentech Collaboration for Dry AMD
Next-Generation Sequencing
Fast and Flexible: Singular’s G4 Takes Aim at Illumina’s Sequencing Superiority
Drug Discovery
Vikram Bajaj, PhD: “Innovation Doesn’t Come from Boston and San Francisco Alone”
A-Lists
Six of the Best Reports from the Front Line of Biotechnology
Gene Expression
Signal Indications: Foghorn Targets Cancer with Up-to-$1.7B Lilly Partnership, and Looks Ahead
Protein Therapeutics
GRO-ing the Alphabet: George Church Spinout Engineers Bespoke Protein Therapeutics
Alzheimers
Part III: Hank Zetterberg, MD, PhD, Offers Insights into Alzheimer’s Biomarkers
Alzheimers
Part II: LEXEO CEO R. Nolan Townsend Discusses Pioneering Alzheimer’s Gene Therapy
Alzheimers
Part I: MassGeneral’s Rudy Tanzi, PhD, Shares New Genetic Findings on Alzheimer’s
Cardiovascular Disease
An App a Day Keeps the Doctor Away: Better Therapeutics Targets Behaviors Driving Cardiometabolic Disease
Gene Therapy
Helen Sabzevari, PhD, of Precigen Connects Cancer and the Immune System on “Close to the Edge”
HBV
And Then There Were Four: VBI Scores First FDA Approval with Hepatitis B Vaccine
Molecular Biology
George Church, PhD, Recounts Decades of Research, 38 Companies on “Close to the Edge”
Epigenetics
The Drug Dogma: Omega Therapeutics Takes Command of Disease with Epigenetic Medicine
T Cells
Mapping Function: Translating Adaptive Immune System Insights into Diagnostics and Drugs
Protein Therapeutics
Next Generation: Growing Protein Therapeutics Developer Raises $370M
Gene Therapy
Beleaguered Bluebird’s New CEO Charts Comeback Course with “Zero Distractions”
Bioprocessing
Smoother Waters: Turnaround Pays Dividends in Q3
Cell Therapy
Intelligent Cells: Shoreline Builds Immunotherapy Platform, Pipeline with $140M Financing
Amgen
Brain Wave: Neumora Aims Precision Medicine at Neuro Diseases with $500M Launch, Amgen Alliance
Drug Discovery
Sending a Message: ReCode is Delivering Genetic Medicines with Lipid Nanoparticle
Molecular Biology
Medidata and Beyond: A Visit with Astronaut Glen de Vries
Artificial Intelligence
From Atlas to Actuary: Immunai Expands Immune Mapping with $215M in Series B
Cell Therapy
Eric Ostertag, MD, PhD, Recounts His Journey from Penn Grad to Poseida CEO on “Close to the Edge”
AAV (Adeno-associated virus)
Going Viral: Dyno Therapeutics Is Broadening the Reach of In Vivo Gene Therapies
Load more
Scroll Up
